Education
About Us
Working with TipRanks
Follow Us
IDT Australia Limited (AU:IDT)
:IDT
IDT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.15
Previous CloseN/A
Volume22.00K
Average Volume (3M)298.13K
Market Cap
AU$41.35M
Enterprise ValueAU$43.24M
Total Cash (Recent Filing)AU$9.06M
Total Debt (Recent Filing)AU$346.00K
Price to Earnings (P/E)―
Beta1.25
Next Earnings
Sep 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 12, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding429,677,860
10 Day Avg. Volume455,368
30 Day Avg. Volume298,129
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
IDT Australia Limited News
PremiumCompany Announcements
IDT Australia Director Increases Stake in Company
PremiumCompany Announcements
IDT Australia Secures $3.2M Contract for NPI-001 Manufacturing
PremiumCompany Announcements
IDT Australia Limited Announces Cessation of Performance Rights
PremiumCompany Announcements
IDT Australia Reports Strong H1FY25 Performance and Strategic Expansions
PremiumCompany Announcements
IDT Australia Sees Revenue Surge Despite Ongoing Losses
PremiumCompany Announcements
IDT Australia Sees Record Revenue Growth Amid Strategic ShiftPremiumCompany Announcements
IDT Australia Secures $20 Million Loan Facility for Expansion
PremiumCompany Announcements
IDT Australia Secures $20 Million Loan for Growth---
Options Prices
Currently, No data available
---
Ownership Overview
0.30%
Insiders
―
Mutual Funds
― Other Institutional Investors
99.70% Public Companies and
Individual Investors
IDT FAQ
What was IDT Australia Limited’s price range in the past 12 months?
IDT Australia Limited lowest share price was AU$0.08 and its highest was AU$0.14 in the past 12 months.
What is IDT Australia Limited’s market cap?
IDT Australia Limited’s market cap is AU$41.35M.
When is IDT Australia Limited’s upcoming earnings report date?
IDT Australia Limited’s upcoming earnings report date is Sep 02, 2025 which is in 132 days.
How were IDT Australia Limited’s earnings last quarter?
IDT Australia Limited released its earnings results on Feb 18, 2025. The company reported -AU$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.008.
Is IDT Australia Limited overvalued?
According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued.
Does IDT Australia Limited pay dividends?
IDT Australia Limited pays a Annually dividend of AU$0.009 which represents an annual dividend yield of N/A. See more information on IDT Australia Limited dividends here
What is IDT Australia Limited’s EPS estimate?
IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IDT Australia Limited have?
IDT Australia Limited has 429,677,860 shares outstanding.
What happened to IDT Australia Limited’s price movement after its last earnings report?
IDT Australia Limited reported an EPS of -AU$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of IDT Australia Limited?
Currently, no hedge funds are holding shares in AU:IDT
---
IDT Australia Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IDT Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$24.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
6.38%
12-Months-Change
Fundamentals
Return on Equity
-19.31%
Trailing 12-Months
Asset Growth
30.67%
Trailing 12-Months
Company Description
IDT Australia Limited
IDT Australia Limited (IDT) is a pharmaceutical manufacturing company based in Australia. It specializes in the development, production, and supply of high-quality pharmaceutical products. The company operates within the pharmaceutical sector, focusing on both proprietary and contract manufacturing services. IDT's core products and services include the production of active pharmaceutical ingredients (APIs) and finished dosage forms, as well as offering services related to clinical research and development.
---
Technical Analysis
CSL
―
Cynata Therapeutics Limited
―
Starpharma Holdings Limited
―
Recce Pharmaceuticals Ltd.
―
---